Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

NCT02272777

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Nanjing, Jiangsu, China
View Trial Details
Completed

Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib

NCT02348957

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Praxis für Hämatologie und internistische Onkologie Heidenheim, Baden-Wurttemberg, Germany
  • Ambulantes Therapiezentrum Offenburg, Baden-Wurttemberg, Germany
  • Diakonie-Klinikum Schwäbisch Hall GmbH, Klinik für Innere Medizin III Schwäbisch Hall, Baden-Wurttemberg, Germany
  • Praxisklinik für integrative Onkologie Altötting, Bavaria, Germany
View all 66 locations
View Trial Details
Completed

Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)

NCT03421626

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Broward Oncology Associates Fort Lauderdale, Florida, United States
  • St. Alphonsus Regional Medical Center Boise, Idaho, United States
  • WJB Dorn VA Medical Center Columbia, South Carolina, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details

Related conditions